23426 Federal Register / Vol. 74, No. 95 / Tuesday, May 19, 2009 / Notices 

Review Branch, Division of Extramural 

Research, NINDS/NIH/DHHS/Neuroscience 

Center, 6001 Executive Blvd., Suite 3208, 

MSC 9529, Bethesda, MD 20852. (301) 435– 

6033. rajarams@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: National Institute of 

Neurological Disorders and Stroke Special 

Emphasis Panel, Hemorrhage Trial. 

Date: June 10, 2009. 

Time: 4 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852. (Telephone 

Conference Call.) 

Contact Person: Richard D. Crosland, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, Division of Extramural 

Research, NINDS/NIH/DHHS/Neuroscience 

Center, 6001 Executive Blvd., Suite 3208, 

MSC 9529, Bethesda, MD 20892–9529. 301– 

594–0635. rc218u@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.853, Clinical Research 

Related to Neurological Disorders; 93.854, 

Biological Basis Research in the 

Neurosciences, National Institutes of Health, 

HHS) 

Dated: May 12, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–11584 Filed 5–18–09; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Deafness and Other Communication 

Disorders. Special Emphasis Panel. RFP 

Auditory Nerve. 

Date: June 4, 2009. 

Time: 11 a.m. to 12:30 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6120 

Executive Blvd., Rockville, MD 20852. 

(Telephone Conference Call). 

Contact Person: Sheo Singh, PhD, 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

Executive Plaza South, Room 400C, 6120 

Executive Blvd., Bethesda, MD 20892. 301– 

496–8683. singhs@nidcd.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, HHS) 

Dated: May 11, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–11480 Filed 5–18–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2009–N–0664] 

Gastrointestinal Drugs Advisory 

Committee; Cancellation 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The meeting of the 

Gastrointestinal Drugs Advisory 

Committee scheduled for May 20, 2009, 

is cancelled. This meeting was 

announced in the Federal Register of 

April 7, 2009 (74 FR 15739). The FDA’s 

Center for Drug Evaluation and Research 

is continuing to review the application 

that was going to be discussed by the 

committee. 

FOR FURTHER INFORMATION CONTACT: 

Kristine T. Khuc, Center for Drug 

Evaluation and Research (HFD–21), 

Food and Drug Administration, 5630 

Fishers Lane (for express delivery, 5630 

Fishers Lane, rm. 1093), Rockville, MD 

20857, 301–827–7001, FAX: 301–827– 

6776, e-mail: 

Kristine.Khuc@fda.hhs.gov, or FDA 

Advisory Committee Information Line, 

1–800–741–8138 (301–443–0572 in the 

Washington, DC area), code 

3014512538. Please call the Information 

Line for up-to-date information on this 

meeting. 

Dated: May 14, 2009. 

Randall W. Lutter, 

Deputy Commissioner for Policy. 

[FR Doc. E9–11725 Filed 5–15–09; 4:15 pm] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HOUSING AND 

URBAN DEVELOPMENT 

[Docket No. FR–5281–N–35] 

Supplement to Application for 

Federally Assisted Housing 

AGENCY: Office of the Chief Information 

Officer, HUD. 

ACTION: Notice. 

SUMMARY: The proposed information 

collection requirement described below 

has been submitted to the Office of 

Management and Budget (OMB) for 

review, as required by the Paperwork 

Reduction Act. The Department is 

soliciting public comments on the 

subject proposal. 

Section 644 of the Housing and 

Community Development Act of 1992 

(42 U.S.C. 13604) imposed on HUD the 

obligation to require housing providers 

participating in HUD’s assisted housing 

programs to provide any individual or 

family applying for occupancy in HUDassisted housing with the option to 

include in the application for 

occupancy the name, address, telephone 

number, and other relevant information 

of a family member, friend, or person 

associated with a social, health, 

advocacy, or similar organization. The 

objective of providing such information, 

if this information is provided, and if 

the applicant becomes a tenant, is to 

facilitate contact by the housing 

provider with the person or organization 

identified by the tenant, to assist in 

providing the delivery of any services or 

special care to the tenant and assist with 

resolving any tenancy issues arising 

during the tenancy of such tenant. This 

supplemental application information is 

to be maintained by the housing 

provider and maintained as confidential 

information. 

DATES: Comments Due Date: June 18, 

2009. 

ADDRESSES: Interested persons are 

invited to submit comments regarding 

this proposal. Comments should refer to 

the proposal by name and/or OMB 

approval Number (2502–Pend) and 

should be sent to: HUD Desk Officer, 

Office of Management and Budget, New 

Executive Office Building, Washington, 

DC 20503; fax: 202–395–6974. 

FOR FURTHER INFORMATION CONTACT: 

Lillian Deitzer, Reports Management 

mstockstill on PROD1PC66 with NOTICES